9
Participants
Start Date
June 7, 2018
Primary Completion Date
September 3, 2020
Study Completion Date
September 3, 2020
rVA576
6 months of treatment, rVA576 plus SOC. Followed by a further 3 months of rVA576 plus SOC. In total, 9 months on rVA576 plus SOC.
Standard of care (SOC)
6 months on SOC followed by 3 months of treatment with rVA576 plus SOC. In total, 3 months on rVA576 plus SOC.
Almaty City Hospital No.7, Almaty
Vilnius University Hospital Santaros Klinikos , Santariškių St. 2, LT-08661,, Vilnius
University of Kelaniya, Faculty of Medicine, Thalagolla Road, Colombo
Lead Sponsor
AKARI Therapeutics
INDUSTRY